Press Release

Institut Straumann AG, Danaher and Dentsply Sirona are dominating the Belgium And Netherlands Dental Implants Market in 2019

Netherlands and Belgium dental implants market is expected to reach USD 377.27 million by 2026 from USD 228.42 million in 2018, growing at a CAGR of 6.5% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at

The Belgium and Netherlands dental implants market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to increasing prevalence of dental diseases and disorders, increase demand for cosmetic dentistry, increasing number of geriatric population and advanced product development.

The market has witnessed developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative technology in the maintenance of aseptic processing of pharmaceutical products. For instance, In April 2015, Straumann has signed an agreement to increase its ownership of Neodent, a Latin American dental implant company, from 49% to 100% in 2015. Neodent is highly profitable, and the acquisition will be accretive to Straumann’s reported EBIT margin from 2016. These two companies will be able merging certain activities and providing better services to its customers. Such developments will only lead to a healthy future for Belgium and Netherlands dental implants market.

Institut Straumann AG dominated the Belgium and Netherlands dental implants market and accounts for the highest market share in 2018 which is followed by Danaher and Dentsply Sirona. The other key players existing in the market includes Henry Schein, Inc., Zimmer Biomet, Bicon, LLC, Adin Dental Implant Systems Ltd., Sigdent Dental Implants, Institut Straumann AG, Sweden & Martina S.p.A., BEGO GmbH & Co. KG, Neobiotech, Neoss Limited and Proscan and others.

Institut Straumann AG:

Institut Straumann AG headquartered in Basel, Switzerland was founded in 1954. The company focuses on delivering products that stand for excellence, innovation and quality in tooth replacement and aesthetics. The company has six operating product categories such as Implantology Confidence, Prosthetic Efficiency, Advanced Biomaterials, Digital Performance, Orthodontics Integrated and Others. The market focused category lies under Implantology Confidence category. The company operates under three business segments which are Implant solutions, Restorative solutions and others and the market focussed segment is Implant solutions. The revenue of Implant solutions has increased by 16.82% compared to previous year.

It has its global networks through direct sales representatives and distributors in the South America, North America, Asia-Pacific, Africa, Europe and Middle East. The company has various subsidiaries such as Manohay Dental SA (Spain), Equinox Implants LLP (India), Straumann Italia srl (Italy), Neodent/Straumann (Brazil), Straumann AS (Norway) among others.


Danaher headquartered in Pennsylvania, U.S was founded in 1969. The company is engaged in helping customers achieve high standards by innovating forward-looking technologies to solve customers’ most complex challenges. The company has two product categories; Implant direct and Nobel biocare. The product categories as per Implant direct are Implants, Prosthetics, Biomaterial, Instruments, Restoratives, Education. Nobel biocare offers products under the categories of Implant Systems, Prosthetic Solutions, Treatment Concepts, Regenerative Solutions, Library, Authentication tool, Track & Trace and Drill units. According to the annual report of 2018 the employees work in Danaher were 77,000. The company operates through four business segments which are Life Science, Diagnostics, Dental, and Environmental & Applied Solutions. Dental is market focused segment whose revenue has increased by 8.5% as compared to 2017 because of increase in demand of company’s products and sales growth rates in high-growth markets.

Its global presence is in Asia-Pacific, Europe, North America, South America, Middle East and Africa. It operates through its subsidiaries such as Ormco Corporation (U.S.) and Nobel Biocare Services AG (Switzerland).

Dentsply Sirona:

Dentsply Sirona is headquartered in Pennsylvania, U.S. founded in 2016. The company is engaged in the manufacturing of professional dental solutions. The company operates through two business segments which include Technologies & Equipment, Consumables and the market focussed segment is Technologies & Equipment. According to the annual report of 2018, the employees in the company were 16,400. In 2018, net sales of technologies & equipment segment have decreased by 0.2% compared to the year 2017 due to the due to the weakening of the U.S. dollar over the prior period.

Dentsply Sirona offers various innovative dental solutions such as Endodontics, Implantology, Dental Labs, Restorative, Orthodontics, Treatment Centres, Imaging Systems, Instruments, Infection Control Systems, CEREC, Digital Impression.

The company has wide geographic presence in North America, South America, Europe, Asia Pacific, Middle East & Africa. It operates through its subsidiaries such as Dentsply LLC (U.S.), Friadent GmbH (Germany), DeguDent (Germany), Dentsply France SAS (France), ElephantDental BV (Netherlands) and others.

Client Testimonials